Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.
Lemoli RM, Fortuna A, Tafuri A, Fogli M, Amabile M, Grande A, Ricciardi MR, Petrucci MT, Bonsi L, Bagnara G, Visani G, Martinelli G, Ferrari S, Tura S. Lemoli RM, et al. Among authors: amabile m. Blood. 1996 May 1;87(9):3852-9. Blood. 1996. PMID: 8611712 Free article.
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.
Lemoli RM, Salvestrini V, Bianchi E, Bertolini F, Fogli M, Amabile M, Tafuri A, Salati S, Zini R, Testoni N, Rabascio C, Rossi L, Martin-Padura I, Castagnetti F, Marighetti P, Martinelli G, Baccarani M, Ferrari S, Manfredini R. Lemoli RM, et al. Among authors: amabile m. Blood. 2009 Dec 10;114(25):5191-200. doi: 10.1182/blood-2008-08-176016. Blood. 2009. PMID: 19855080 Free article.
Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
Lemoli RM, Fortuna A, Motta MR, Rizzi S, Giudice V, Nannetti A, Martinelli G, Cavo M, Amabile M, Mangianti S, Fogli M, Conte R, Tura S. Lemoli RM, et al. Among authors: amabile m. Blood. 1996 Feb 15;87(4):1625-34. Blood. 1996. PMID: 8608257 Free article. Clinical Trial.
Interleukin-9 in human myeloid leukemia cells.
Lemoli RM, Fortuna A, Tafuri A, Grande A, Amabile M, Martinelli G, Ferrari S, Tura S. Lemoli RM, et al. Among authors: amabile m. Leuk Lymphoma. 1997 Aug;26(5-6):563-73. doi: 10.3109/10428199709050892. Leuk Lymphoma. 1997. PMID: 9389363
Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
Buonamici S, Ottaviani E, Testoni N, Montefusco V, Visani G, Bonifazi F, Amabile M, Terragna C, Ruggeri D, Piccaluga PP, Isidori A, Malagola M, Baccarani M, Tura S, Martinelli G. Buonamici S, et al. Among authors: amabile m. Blood. 2002 Jan 15;99(2):443-9. doi: 10.1182/blood.v99.2.443. Blood. 2002. PMID: 11781223 Free article.
A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.
Baccarani M, Rosti G, de Vivo A, Bonifazi F, Russo D, Martinelli G, Testoni N, Amabile M, Fiacchini M, Montefusco E, Saglio G, Tura S; Italian Cooperative Study Group on Myeloid Leukemia. Baccarani M, et al. Among authors: amabile m. Blood. 2002 Mar 1;99(5):1527-35. doi: 10.1182/blood.v99.5.1527. Blood. 2002. PMID: 11861264 Free article. Clinical Trial.
166 results